Bio-Rad and Bruker launch biomarker purification product
This article was originally published in Clinica
Bio-Rad Laboratories and Bruker have launched the Lucid ID Access Pack, a device to help purify and identify biomarkers, in the US and Europe. The pack is the first for use with the Lucid Proteomics System, a joint venture from the two companies. It is designed to work with Bruker's ultrafleXtreme MALDI-TOF/TOF mass spectrometer, which the firm launched in April. The Lucid Proteomics System is the only device to combine both "top-down" and "bottom-up" approaches for biomarker discovery, the companies claim. The top-down approach enables the discovery of proteins under 30kDa, and the bottom-down method is better for proteins with higher masses – combining both allows the system to cover the whole spectrum of biomarkers.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.